This report was recently updated on November 15 2024 with the latest and most recent
market numbers
Global Automatic Insulin Dose Adjustment Software Market Size, Trends & Analysis - Forecasts to 2029 By Price Model (Subscription-based and One-time Purchase), By Type of Software (Closed-loop Systems and Open-loop Systems), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global automatic insulin dose adjustment software market is estimated to exhibit a CAGR of 8.2% from 2024 to 2029.
The primary factors propelling the market growth are the increasing prevalence of diabetes and the growing adoption of continuous glucose monitoring (CGM) systems. As the incidence of diabetes rises globally, there is an increasing demand for advanced diabetes treatment options to manage the condition effectively. This demand is fueling the adoption of insulin management solutions that offer automated diabetes treatment through precision insulin dosing. Moreover, diabetes management may be difficult and time-consuming, requiring regular monitoring of insulin dosages and blood glucose levels. By automating dosage modifications based on customized algorithms, automatic insulin dose adjustment software streamlines this procedure and improves patient convenience and compliance. For instance, according to International Diabetes Federation (IDF) forecasts from 2021, 1 in 8 individuals worldwide, or 783 million, would have diabetes by 2045, a 46% rise.
Emphasis on personalized diabetes care solutions and the increasing reliance on digital health technologies are expected to support the market growth. With diabetes management becoming increasingly individualized, there is a growing demand for innovative insulin-dosing solutions that cater to each patient's unique needs. This demand fuels the adoption of automatic insulin dose adjustment software, which offers remote insulin dose monitoring and real-time glucose management. Additionally, by giving patients the power to actively participate in their own treatment and include them in the decision-making process, personalized diabetes care solutions increase patient satisfaction and engagement. Software that automatically adjusts insulin dosages makes it easier for patients and healthcare professionals to communicate, enabling prompt treatment plan modifications depending on patient preferences and offers patient-centric insulin adjustment.
Advances in AI-driven healthcare technologies and the rising need for sophisticated diabetes management software fuel market growth. The swift advancement of artificial intelligence (AI) has brought about a notable shift in the way diabetic care is treated. This transformation is evident in AI-powered insulin optimization, smart insulin delivery systems, and the broader integration of smart healthcare technology. Moreover, compared to conventional techniques, AI systems are able to more precisely forecast future blood glucose levels by analyzing intricate patterns in patient data.
The market presents significant opportunities driven by the increasing demand for integrated insulin therapy solutions. These systems support market growth by streamlining insulin delivery, enhancing patient adherence, and providing tailored treatment alternatives. Furthermore, advanced algorithms, artificial intelligence, and machine learning are all incorporated into next-generation diabetes management systems to provide individualized insulin dose recommendations that improve patient outcomes and quality of life, which is creating opportunities in the market.
However, lack of awareness among patients and interoperability issues with existing healthcare systems impede market growth.
The subscription-based segment is expected to hold the largest share of the market over the forecast period. Subscription-based models offer software vendors a predictable and recurring revenue stream. Due to this consistent revenue stream, companies are better able to predict their financial success and plan for future expenditures in R&D and customer support.
The one-time purchase segment is expected to be the fastest-growing segment in the market from 2024 to 2029. One-time purchase models offer greater customization options or additional features compared to subscription-based alternatives. This added value attracts users who prioritize tailored solutions for their specific healthcare needs.
The open-loop systems segment is expected to hold the largest share of the market over the forecast period. Open-loop systems give patients and healthcare professionals more alternatives for personalization and flexibility. With more control over insulin dosage, users can create customized treatment regimens based on their own requirements, preferences, and lifestyle choices.
The closed-loop systems segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Closed-loop systems provide a complete diabetes management solution by automatically modifying insulin supply in response to real-time glucose measurement. By imitating the actions of a functioning pancreas, these devices seek to improve glycemic control and lower the risk of hypo- and hyperglycemia.
North America is expected to be the largest region in the global market. The increasing use of digital health solutions, including wearable technology and mobile health applications, has generated a favorable atmosphere for adopting software that automatically adjusts insulin dosage, propelling the market growth in the region. These technologies offer convenience, real-time monitoring, and seamless integration with other healthcare systems.
Asia Pacific is anticipated to witness rapid growth during the forecast period. Aiming to improve access to high-quality healthcare services and manage chronic illnesses, many Asia Pacific nations are implementing healthcare policies. Market growth is fueled by government funding programs, financing efforts, and regulatory frameworks that encourage the use of digital health technology, such as software for automatically adjusting insulin dosage.
Glytec, Beta Bionics Inc., Hygieia, Tandem Diabetics, CamDiab, Medtronic, Novo Nordisk, Omnipod, Tempo Platform, and Abbott, among others, are some of the key players operating in the global automatic insulin dose adjustment software market.
Please note: This is not an exhaustive list of companies profiled in the report.
In April 2024, Glytec declared its support of the significant new Centers for Medicare and Medicaid Services (CMS) initiatives aimed at enhancing the reporting of diabetes.
In May 2023, the U.S. Food and Drug Administration (FDA) approved Beta Bionics' iLet ACE Pump and iLet Dosing Decision Software for the treatment of type 1 diabetes in patients six years of age and older.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL AUTOMATIC INSULIN DOSE ADJUSTMENT SOFTWARE MARKET, BY Price Model
4.1 Introduction
4.2 Automatic Insulin Dose Adjustment Software Market: Price Model Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Subscription-based
4.4.1 Subscription-based Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 One-time Purchase
4.5.1 One-time Purchase Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL AUTOMATIC INSULIN DOSE ADJUSTMENT SOFTWARE MARKET, BY TYPE OF SOFTWARE
5.1 Introduction
5.2 Automatic Insulin Dose Adjustment Software Market: Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Closed-loop Systems
5.4.1 Closed-loop Systems Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Open-loop Systems
5.5.1 Open-loop Systems Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL AUTOMATIC INSULIN DOSE ADJUSTMENT SOFTWARE MARKET, BY REGION
6.1 Introduction
6.2 North America Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Price Model
6.2.2 By Type of Software
6.2.3 By Country
6.2.3.1 U.S. Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Price Model
6.2.3.1.2 By Type of Software
6.2.3.2 Canada Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Price Model
6.2.3.2.2 By Type of Software
6.2.3.3 Mexico Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Price Model
6.2.3.3.2 By Type of Software
6.3 Europe Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Price Model
6.3.2 By Type of Software
6.3.3 By Country
6.3.3.1 Germany Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Price Model
6.3.3.1.2 By Type of Software
6.3.3.2 U.K. Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Price Model
6.3.3.2.2 By Type of Software
6.3.3.3 France Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Price Model
6.3.3.3.2 By Type of Software
6.3.3.4 Italy Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Price Model
6.3.3.4.2 By Type of Software
6.3.3.5 Spain Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Price Model
6.3.3.5.2 By Type of Software
6.3.3.6 Netherlands Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Price Model
6.3.3.6.2 By Type of Software
6.3.3.7 Rest of Europe Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Price Model
6.3.3.6.2 By Type of Software
6.4 Asia Pacific Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Price Model
6.4.2 By Type of Software
6.4.3 By Country
6.4.3.1 China Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Price Model
6.4.3.1.2 By Type of Software
6.4.3.2 Japan Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Price Model
6.4.3.2.2 By Type of Software
6.4.3.3 India Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Price Model
6.4.3.3.2 By Type of Software
6.4.3.4 South Korea Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Price Model
6.4.3.4.2 By Type of Software
6.4.3.5 Singapore Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Price Model
6.4.3.5.2 By Type of Software
6.4.3.6 Malaysia Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Price Model
6.4.3.6.2 By Type of Software
6.4.3.7 Thailand Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Price Model
6.4.3.6.2 By Type of Software
6.4.3.8 Indonesia Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Price Model
6.4.3.7.2 By Type of Software
6.4.3.9 Vietnam Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Price Model
6.4.3.8.2 By Type of Software
6.4.3.10 Taiwan Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Price Model
6.4.3.10.2 By Type of Software
6.4.3.11 Rest of Asia Pacific Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Price Model
6.4.3.11.2 By Type of Software
6.5 Middle East and Africa Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Price Model
6.5.2 By Type of Software
6.5.3 By Country
6.5.3.1 Saudi Arabia Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Price Model
6.5.3.1.2 By Type of Software
6.5.3.2 U.A.E. Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Price Model
6.5.3.2.2 By Type of Software
6.5.3.3 Israel Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Price Model
6.5.3.3.2 By Type of Software
6.5.3.4 South Africa Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Price Model
6.5.3.4.2 By Type of Software
6.5.3.5 Rest of Middle East and Africa Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Price Model
6.5.3.5.2 By Type of Software
6.6 Central and South America Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Price Model
6.6.2 By Type of Software
6.6.3 By Country
6.6.3.1 Brazil Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Price Model
6.6.3.1.2 By Type of Software
6.6.3.2 Argentina Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Price Model
6.6.3.2.2 By Type of Software
6.6.3.3 Chile Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Price Model
6.6.3.3.2 By Type of Software
6.6.3.3 Rest of Central and South America Automatic Insulin Dose Adjustment Software Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Price Model
6.6.3.3.2 By Type of Software
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Glytec
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Beta Bionics Inc.
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 Hygieia
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Tandem Diabetics
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 CamDiab
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 MEDTRONIC
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Novo Nordisk
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Omnipod
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Tempo Platform
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Abbott
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Type of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
2 Subscription-based Market, By Region, 2021-2029 (USD Mllion)
3 One-time Purchase Market, By Region, 2021-2029 (USD Mllion)
4 Global Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
5 Closed-loop Systems Market, By Region, 2021-2029 (USD Mllion)
6 Open-loop Systems Market, By Region, 2021-2029 (USD Mllion)
7 Regional Analysis, 2021-2029 (USD Mllion)
8 North America Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
9 North America Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
10 North America Automatic Insulin Dose Adjustment Software Market, By COUNTRY, 2021-2029 (USD Mllion)
11 U.S. Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
12 U.S. Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
13 Canada Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
14 Canada Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
15 Mexico Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
16 Mexico Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
17 Europe Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
18 Europe Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
19 EUROPE Automatic Insulin Dose Adjustment Software Market, By COUNTRY, 2021-2029 (USD Mllion)
20 Germany Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
21 Germany Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
22 U.K. Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
23 U.K. Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
24 France Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
25 France Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
26 Italy Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
27 Italy Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
28 Spain Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
29 Spain Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
30 Netherlands Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
31 Netherlands Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
32 Rest Of Europe Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
33 Rest Of Europe Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
34 Asia Pacific Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
35 Asia Pacific Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
36 ASIA PACIFIC Automatic Insulin Dose Adjustment Software Market, By COUNTRY, 2021-2029 (USD Mllion)
37 China Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
38 China Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
39 Japan Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
40 Japan Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
41 India Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
42 India Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
43 South Korea Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
44 South Korea Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
45 Singapore Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
46 Singapore Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
47 Thailand Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
48 Thailand Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
49 Malaysia Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
50 Malaysia Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
51 Indonesia Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
52 Indonesia Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
53 Vietnam Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
54 Vietnam Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
55 Taiwan Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
56 Taiwan Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
57 Rest of APAC Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
58 Rest of APAC Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
59 Middle East and Africa Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
60 Middle East and Africa Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
61 MIDDLE EAST & ADRICA Automatic Insulin Dose Adjustment Software Market, By COUNTRY, 2021-2029 (USD Mllion)
62 Saudi Arabia Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
63 Saudi Arabia Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
64 UAE Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
65 UAE Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
66 Israel Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
67 Israel Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
68 South Africa Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
69 South Africa Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
70 Rest Of Middle East and Africa Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
71 Rest Of Middle East and Africa Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
72 Central and South America Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
73 Central and South America Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
74 CENTRAL AND SOUTH AMERICA Automatic Insulin Dose Adjustment Software Market, By COUNTRY, 2021-2029 (USD Mllion)
75 Brazil Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
76 Brazil Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
77 Chile Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
78 Chile Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
79 Argentina Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
80 Argentina Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
81 Rest Of Central and South America Automatic Insulin Dose Adjustment Software Market, By Price Model, 2021-2029 (USD Mllion)
82 Rest Of Central and South America Automatic Insulin Dose Adjustment Software Market, By Type of Software, 2021-2029 (USD Mllion)
83 Glytec: Products & Services Offering
84 Beta Bionics Inc.: Products & Services Offering
85 Hygieia: Products & Services Offering
86 Tandem Diabetics: Products & Services Offering
87 CamDiab: Products & Services Offering
88 MEDTRONIC: Products & Services Offering
89 Novo Nordisk: Products & Services Offering
90 Omnipod: Products & Services Offering
91 Tempo Platform, Inc: Products & Services Offering
92 Abbott: Products & Services Offering
93 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Automatic Insulin Dose Adjustment Software Market Overview
2 Global Automatic Insulin Dose Adjustment Software Market Value From 2021-2029 (USD Mllion)
3 Global Automatic Insulin Dose Adjustment Software Market Share, By Price Model (2023)
4 Global Automatic Insulin Dose Adjustment Software Market Share, By Type of Software (2023)
5 Global Automatic Insulin Dose Adjustment Software Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Automatic Insulin Dose Adjustment Software Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Automatic Insulin Dose Adjustment Software Market
10 Impact Of Challenges On The Global Automatic Insulin Dose Adjustment Software Market
11 Porter’s Five Forces Analysis
12 Global Automatic Insulin Dose Adjustment Software Market: By Price Model Scope Key Takeaways
13 Global Automatic Insulin Dose Adjustment Software Market, By Price Model Segment: Revenue Growth Analysis
14 Subscription-based Market, By Region, 2021-2029 (USD Mllion)
15 One-time Purchase Market, By Region, 2021-2029 (USD Mllion)
16 Global Automatic Insulin Dose Adjustment Software Market: By Type of Software Scope Key Takeaways
17 Global Automatic Insulin Dose Adjustment Software Market, By Type of Software Segment: Revenue Growth Analysis
18 Closed-loop Systems Market, By Region, 2021-2029 (USD Mllion)
19 Open-loop Systems Market, By Region, 2021-2029 (USD Mllion)
20 Global Automatic Insulin Dose Adjustment Software Market: Regional Analysis
21 North America Automatic Insulin Dose Adjustment Software Market Overview
22 North America Automatic Insulin Dose Adjustment Software Market, By Price Model
23 North America Automatic Insulin Dose Adjustment Software Market, By Type of Software
24 North America Automatic Insulin Dose Adjustment Software Market, By Country
25 U.S. Automatic Insulin Dose Adjustment Software Market, By Price Model
26 U.S. Automatic Insulin Dose Adjustment Software Market, By Type of Software
27 Canada Automatic Insulin Dose Adjustment Software Market, By Price Model
28 Canada Automatic Insulin Dose Adjustment Software Market, By Type of Software
29 Mexico Automatic Insulin Dose Adjustment Software Market, By Price Model
30 Mexico Automatic Insulin Dose Adjustment Software Market, By Type of Software
31 Four Quadrant Positioning Matrix
32 Company Market Share Analysis
33 Glytec: Company Snapshot
34 Glytec: SWOT Analysis
35 Glytec: Geographic Presence
36 Beta Bionics Inc.: Company Snapshot
37 Beta Bionics Inc.: SWOT Analysis
38 Beta Bionics Inc.: Geographic Presence
39 Hygieia: Company Snapshot
40 Hygieia: SWOT Analysis
41 Hygieia: Geographic Presence
42 Tandem Diabetics: Company Snapshot
43 Tandem Diabetics: Swot Analysis
44 Tandem Diabetics: Geographic Presence
45 CamDiab: Company Snapshot
46 CamDiab: SWOT Analysis
47 CamDiab: Geographic Presence
48 MEDTRONIC: Company Snapshot
49 MEDTRONIC: SWOT Analysis
50 MEDTRONIC: Geographic Presence
51 Novo Nordisk : Company Snapshot
52 Novo Nordisk : SWOT Analysis
53 Novo Nordisk : Geographic Presence
54 Omnipod: Company Snapshot
55 Omnipod: SWOT Analysis
56 Omnipod: Geographic Presence
57 Tempo Platform, Inc.: Company Snapshot
58 Tempo Platform, Inc.: SWOT Analysis
59 Tempo Platform, Inc.: Geographic Presence
60 Abbott: Company Snapshot
61 Abbott: SWOT Analysis
62 Abbott: Geographic Presence
63 Other Companies: Company Snapshot
64 Other Companies: SWOT Analysis
65 Other Companies: Geographic Presence
The Global Automatic Insulin Dose Adjustment Software Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Automatic Insulin Dose Adjustment Software Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
